Del Velour al V aniversario ¿Qué hemos aprendido y qué nos queda por aprender?

- Personal financial interests:

Advisory role:

Roche, Novartis

Speaker’s fee:

Roche, Symphogen, Ipsen, Amgen, Sanofi

Direct research fund: Merck

- Institutional financial interests:

Clinical trial support: Agendia, Amgen, Debiopharm, Janssen-Cilag, Merck, MSD,

Novartis, Pharma Mar, Roche, Sanofi, Servier, Symphogen.

Disclosure slide